Takuhei Yokoyama

Significance of histologic pattern of carcinoma and sarcoma components on survival outcomes of uterine carcinosarcoma

Koji Matsuo, Yutaka Takazawa, Malcolm S. Ross et al. · Annals of Oncology · 2016 · 106 citations · Full text

Veterinary Medicine, Oncology, Pathology +14

Prexasertib, a cell cycle checkpoint kinases 1 and 2 inhibitor, increases <i>in vitro</i> toxicity of PARP inhibition by preventing Rad51 foci formation in <i>BRCA</i> wild type high-grade serous ovarian cancer

Ethan Brill, Takuhei Yokoyama, Jayakumar R. Nair et al. · Oncotarget · 2017 · 79 citations · Full text

Medicine, Oncology, Pharmacology +17

Plasma membrane proteomics identifies bone marrow stromal antigen 2 as a potential therapeutic target in endometrial cancer

Takuhei Yokoyama, Takayuki Enomoto, Satoshi Serada et al. · International Journal of Cancer · 2012 · 64 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

LSR Antibody Therapy Inhibits Ovarian Epithelial Tumor Growth by Inhibiting Lipid Uptake

Kosuke Hiramatsu, Satoshi Serada, Takayuki Enomoto et al. · Cancer Research · 2017 · 47 citations

Medicine, Cancer Biology, Oncology +17

Impact of adjuvant therapy on recurrence patterns in stage I uterine carcinosarcoma

Koji Matsuo, Kohei Omatsu, Malcolm S. Ross et al. · Gynecologic Oncology · 2017 · 40 citations

Medicine, Oncology, Surgery +11